Riskpilot← Back to searchSign inGet full accessPea Medi AB
ABActiveOrg 5564669074Krokvägen 12General medical practice activities · NACE 8621Est. 19930 employees
Revenue 2025
SEK 89K
+4753% vs 2024
EBITDA margin
-298.0%
+72% vs 2024
Equity ratio
93.4%
Financial strength
Net profit 2025
SEK 156K
-81% vs 2024
| Revenue | SEK 89K | +4753% |
| EBITDA | SEK -264K | +72% |
| Net profit | SEK 156K | -81% |
| Total assets | SEK 2,7M | -23% |
| Equity | SEK 2,5M | -7% |
| Employees | 0 | — |
Legal name
Pea Medi AB
Org number
5564669074
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 april 1993
Share capital
SEK 101 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukvård samt föreläsningsverksamhet. Vaccinations- och profylax rådgivning i form av publikation och via datamedia till medicinalpersonal samt epidemiologisk kartläggning och därmed förenlig verksamhet.
Address
Krokvägen 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 65 | 70 | 49 | 2 | 89 |
| Staff expenses | — | −1 042 | −362 | −692 | −165 |
| EBITDA | −1 265 | −1 200 | −592 | −955 | −264 |
| Depreciation & amort. | −37 | −74 | — | — | — |
| EBIT | −1 302 | −1 274 | −592 | −955 | −264 |
| Net financials | 828 | 1 520 | 1 270 | 1 129 | 472 |
| Profit before tax | 1 101 | 353 | 818 | 1 044 | 208 |
| Tax | −236 | −82 | −177 | −222 | −52 |
| Net profit | 865 | 271 | 641 | 821 | 156 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 579 | 3 445 | 3 585 | 3 469 | 2 665 |
| Equity | 1 920 | 1 841 | 2 075 | 2 682 | 2 488 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 542 | 594 | 640 | 787 | 177 |
| Total debt | 542 | 594 | 640 | 787 | 177 |
EBITDA margin
-298.0%
This company
15.8%
Market median
-1986% vs market
20212025
Equity ratio
93.4%
This company
38.2%
Market median
+145% vs market
20212025
Return on equity
6.3%
This company
18.4%
Market median
-66% vs market
20212025
Net profit margin
176.6%
This company
8.1%
Market median
+2080% vs market
20212025
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20212025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pea Medi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Lennart Benno | Deputy Board Member | 0 companies |
| Peter Michael Benno | Board of Directors | 0 companies |